Brent Ogilvie is widely respected as an authority in commercialization of life sciences. A former New Zealand Trade Commissioner to New York , Brent is regularly interviewed for comment as seen in the following articles:

The Channel Group was commissioned as global experts by the New Zealand government to provide an external view of its biotechnology industry including an objective review, analysis and strategic framework to support the development of the industry. The government has made a summary of the report (the full report is 160 pages and property of New Zealand government) available at NZ Biotech: External View 

Research and development in life sciences is capital intensive. Lead researchers, business managers and chief scientists need to be able to efficiently review, present to and ultimately access appropriate funding resources internationally, including grant funding. Presentation for venture capital is a well described art.

Pacific Channel Ltd. co-founder Brent S. Ogilvie initiated research to addresses the question: In what respects do potential philanthropic funders of new ventures with biomedical social good applications look for similar, or for different, key factors compared with profit driven venture capital investors, when they receive new venture plans and/or proposals for funding. Please see the article below for more information